NCT06932081Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i (ACHIEVE-SGLT2i) Registry
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 2 Mar 2025
- Start date
- 1 Jan 2023
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Leiden University Medical Center
- Diseases
- Heart failure
- NCT number
- NCT06932081
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Jan 2023 to the primary completion date, 31 Dec 2027
- 11 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- No consent for data collection.
Who the study is looking for
- Congenital heart defect.
- Age ≥ 18 years.
- Initiated on treatment with an SGLT2i.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Heart Center Duisburg (Evangelical Hospital Niederrhein) Coordinator of this site? Confirm its status | Duisburg | Germany | Recruiting |
| University Hospital of Wales Coordinator of this site? Confirm its status | Cardiff | United Kingdom | Recruiting |
| Golden Jubilee University National Hospital Coordinator of this site? Confirm its status | Glasgow | United Kingdom | Recruiting |
| Barts Heart Centre Coordinator of this site? Confirm its status | London | United Kingdom | Recruiting |
| Zan Mitrev Clinic Coordinator of this site? Confirm its status | Skopje | North Macedonia | Recruiting |
| Amsterdam University Medical Center Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Recruiting |
| Leiden University Medical Center (LUMC) Coordinator of this site? Confirm its status | Leiden | Netherlands | Recruiting |
| University Medical Center Utrecht Coordinator of this site? Confirm its status | Utrecht | Netherlands | Recruiting |
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
| Helen DeVos Children's Hospital Coordinator of this site? Confirm its status | Grand Rapids | United States | Recruiting |
| Mount Sinai Fuster Heart Hospital Coordinator of this site? Confirm its status | New York | United States | Recruiting |
Related publications
- Real-world experience with sodium-glucose cotransporter 2 inhibitors in adults with Fontan circulatory failure.Front Cardiovasc Med · 2026 · PMID 42181636
This page is information, not medical advice. Discuss any trial with your doctor.